comparemela.com

Latest Breaking News On - Intravenous route - Page 1 : comparemela.com

Largest CIDP Trial Offers Promising Results for Drug Combo

Nearly 70% of patients showed improvement after treatment with efgartigimod plus rHuPH20 in phase 2 of the largest randomized controlled trial for CIDP to date.

United-states
Denver
Colorado
American
Jeffreya-allen
Brettm-morrison
University-of-minnesota
American-academy-of-neurology
Johns-hopkins-school-of-medicine
Morrison
American-academy

Sub-Q Tocilizumab Gives Durable Long-Term Responses in JIA

Patients with juvenile idiopathic arthritis achieved long-term disease control with subcutaneous tocilizumab treatment, without any new safety concerns, in an LTE study of two trials.

Cincinnati
Ohio
United-states
Herminei-brunner
International-league
Cincinnati-children
Hospital-medical-center
Juvenile-rheumatoid-arthritis
Uvenile-ra
Juvenile-idiopathic-arthritis
Arthritis

Esketamine Linked to Reduced Postpartum Depression Risk

Esketamine Linked to Reduced Postpartum Depression Risk
medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.

Budapest
Hungary
China
Spain
Riga
Latvia
Stradi
Gulbenes-novads
Barcelona
Comunidad-autonoma-de-cataluna
Linda-rubene
Angelina-kozhokar

US FDA Approves Basilea Pharmaceutica's Antibiotic

The U.S. health regulator approved Basilea Pharmaceutica's antibiotic for bacterial infections including multidrug-resistant strains, the FDA said on.

Switzerland
Bengaluru
Karnataka
India
Christy-santhosh
Basilea-pharmaceutica
Sriparna-roy
Vijay-kishore
Soo-romanoff
Reuters
Edison-group
Antibiotics

vimarsana © 2020. All Rights Reserved.